Skip to content
healthcare.dev

Adenosine

NDC 25021-318, Adenosine, injection, from Sagent Pharmaceuticals.

Product NDC
25021-318
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206778
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-318 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ADENOSINE3 mg/mL

Pharmacologic classes

Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]

Package NDCNDC-11Package
25021-318-022502103180210 VIAL in 1 CARTON (25021-318-02) / 2 mL in 1 VIAL
25021-318-042502103180410 VIAL in 1 CARTON (25021-318-04) / 4 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/546642f2-662f-46cf-9d82-5bb3bdcc7677
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25021-318

Use it

Look up 25021-318 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-318 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-318. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.